Physician profile
Brian Ruby
NPI 1598281149
$3,410.93
in general payments reported to CMS, 2019-2025
9 companies · $21.27 in 2025
The $21.27 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,210 · 2022: $53.18 · 2023: $72.58 · 2024: $53.65 · 2025: $21.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $2,752.18 | 2021 | |
| Bioventus LLC | $144.05 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $143.24 | 2021 | |
| Zimmer Biomet Holdings, INC. | $135.77 | 2021 | |
| Pacira Therapeutics, INC. | $107.48 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $61.67 | 2023-2024 | Zilretta, Exparel, Iovera |
| Smith+Nephew, INC. | $30.70 | 2021-2023 | Renasys Go V2 Home, Pico 7 |
| Stryker Corporation | $21.32 | 2024 | Inspace |
| Heraeus Medical, LLC. | $14.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ruby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.